Sandbox Reserved 1735: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Introduction== | ==Introduction== | ||
== Structural Highlights == | == Structural Highlights == | ||
== | == HIV-1 Proteases in Humans== | ||
HIV- | ==HIV-2 Proteases in Humans== | ||
==The role of CD4+ T-cell== | |||
HIV-1 | ==Protease Inhibitors for HIV-1 Treatment== | ||
==Protease Inhibitors for HIV-2 Treatment== | |||
==Evolution's Role== | |||
==HIV Prevention== | |||
This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes. | This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes. | ||
Revision as of 19:44, 14 November 2022
| This Sandbox is Reserved from August 30, 2022 through May 31, 2023 for use in the course Biochemistry I taught by Kimberly Lane at the Radford University, Radford, VA, USA. This reservation includes Sandbox Reserved 1730 through Sandbox Reserved 1749. |
To get started:
More help: Help:Editing |
HIV-1 Protease
| ||||||||||||
